SPNS3 and acute myeloid leukemia: Using GEPIA, we further elucidated the expression of SPNS3 in 38 different types of neoplasms and found that average SPNS3 expression was highest in AML (Figure 1(a)) and was significantly enhanced compared to the expression in the normal tissue samples (P < 0.05) (Figure 1(b)) which suggested that SPNS3 expression might play an important role in the onset and development of AML.